Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dayer

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
Leukemia|March 1, 1994
Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification?F M Laurencet, B Chapuis, P Roux-Lombard, et al.
Rheumatology (Oxford, England)|May 24, 2001
Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year studyP Roux-Lombard, K Eberhardt, T Saxne, et al.
European Cytokine Network|June 12, 2001
Presence of estrogen receptors in human myeloid monocytic cells (THP-1 cell line)M Cutolo, B Villaggio, A Bisso, et al.
Experimental and Molecular Pathology|June 1, 1989
Recombinant human interleukin-1 beta decreases serum carboxypeptidase N and modifies serum amino acid concentrations in ratsJ M Dayer, A Hampai, M Schmidt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity that blocks ligand bindingP Seckinger, J W Lowenthal, K Williamson, et al.
Cellular Immunology|June 1, 1986
Intracellular epidermal interleukin 1-like factors in the human epidermoid carcinoma cell line A431C Hauser, J M Dayer, F Jaunin, et al.
Endocrinology|November 1, 1988
Human recombinant interleukin-1 beta decreases plasma thyroid hormone and thyroid stimulating hormone levels in ratsJ M Dubuis, J M Dayer, C A Siegrist-Kaiser, et al.
The Journal of Clinical Investigation|February 1, 1986
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cellsJ M Dayer, B de Rochemonteix, B Burrus, et al.
Clinical and Experimental Immunology|July 1, 1997
The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type IIK A Kreuzer, J M Dayer, J K Rockstroh, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 1990
Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophagesB Galve-de Rochemonteix, L P Nicod, A F Junod, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
Leukemia|March 1, 1994
Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification?F M Laurencet, B Chapuis, P Roux-Lombard, et al.
Rheumatology (Oxford, England)|May 24, 2001
Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year studyP Roux-Lombard, K Eberhardt, T Saxne, et al.
European Cytokine Network|June 12, 2001
Presence of estrogen receptors in human myeloid monocytic cells (THP-1 cell line)M Cutolo, B Villaggio, A Bisso, et al.
Experimental and Molecular Pathology|June 1, 1989
Recombinant human interleukin-1 beta decreases serum carboxypeptidase N and modifies serum amino acid concentrations in ratsJ M Dayer, A Hampai, M Schmidt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity that blocks ligand bindingP Seckinger, J W Lowenthal, K Williamson, et al.
Cellular Immunology|June 1, 1986
Intracellular epidermal interleukin 1-like factors in the human epidermoid carcinoma cell line A431C Hauser, J M Dayer, F Jaunin, et al.
Endocrinology|November 1, 1988
Human recombinant interleukin-1 beta decreases plasma thyroid hormone and thyroid stimulating hormone levels in ratsJ M Dubuis, J M Dayer, C A Siegrist-Kaiser, et al.
The Journal of Clinical Investigation|February 1, 1986
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cellsJ M Dayer, B de Rochemonteix, B Burrus, et al.
Clinical and Experimental Immunology|July 1, 1997
The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type IIK A Kreuzer, J M Dayer, J K Rockstroh, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 1990
Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophagesB Galve-de Rochemonteix, L P Nicod, A F Junod, et al.
Pageof 29